| SC 13G | 2024-02-14 | SAMLYN CAPITAL, LLC | Corvus Pharmaceuticals, Inc. | 2,496,259 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-13 | MILLER RICHARD A MD | Corvus Pharmaceuticals, Inc. | 3,684,010 | 7.2% | EDGAR |
| SC 13G/A | 2023-02-14 | TANG CAPITAL PARTNERS LP | Corvus Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-13 | CHI Advisors LLC | Corvus Pharmaceuticals, Inc. | 2,384,402 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-10 | MILLER RICHARD A MD | Corvus Pharmaceuticals, Inc. | 3,105,121 | 6.4% | EDGAR |
| SC 13G/A | 2023-01-30 | INTEGRATED CORE STRATEGIES (US) LLC | Corvus Pharmaceuticals, Inc. | 1,888,732 | 4.1% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Corvus Pharmaceuticals, Inc. | 730,485 | 1.6% | EDGAR |
| SC 13G/A | 2022-02-14 | MILLER RICHARD A MD | Corvus Pharmaceuticals, Inc. | 2,607,148 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Venrock Healthcare Capital Partners II, L.P. | Corvus Pharmaceuticals, Inc. | 250,000 | 0.5% | EDGAR |
| SC 13G/A | 2022-02-14 | TANG CAPITAL PARTNERS LP | Corvus Pharmaceuticals, Inc. | 3,101,709 | 6.7% | EDGAR |
| SC 13G/A | 2022-01-18 | INTEGRATED CORE STRATEGIES (US) LLC | Corvus Pharmaceuticals, Inc. | 2,235,609 | 4.8% | EDGAR |
| SC 13G | 2021-12-06 | INTEGRATED CORE STRATEGIES (US) LLC | Corvus Pharmaceuticals, Inc. | 2,094,401 | 4.5% | EDGAR |
| SC 13D/A | 2021-11-03 | ORBIMED ADVISORS LLC | Corvus Pharmaceuticals, Inc. | 6,943,654 | 14.9% | EDGAR |
| SC 13G | 2021-10-22 | INTEGRATED CORE STRATEGIES (US) LLC | Corvus Pharmaceuticals, Inc. | 1,632,751 | 3.8% | EDGAR |
| SC 13G/A | 2021-10-05 | EcoR1 Capital, LLC | Corvus Pharmaceuticals, Inc. | 81,077 | 0.2% | EDGAR |
| SC 13G | 2021-09-30 | Venrock Healthcare Capital Partners II, L.P. | Corvus Pharmaceuticals, Inc. | 3,427,461 | 8.1% | EDGAR |
| SC 13G/A | 2021-09-23 | EcoR1 Capital, LLC | Corvus Pharmaceuticals, Inc. | 5,081,077 | 12.0% | EDGAR |
| SC 13D/A | 2021-09-22 | ORBIMED ADVISORS LLC | Corvus Pharmaceuticals, Inc. | 6,943,654 | 16.4% | EDGAR |
| SC 13G | 2021-09-22 | TANG CAPITAL PARTNERS LP | Corvus Pharmaceuticals, Inc. | 3,736,184 | 8.8% | EDGAR |
| SC 13D/A | 2021-08-04 | ORBIMED ADVISORS LLC | Corvus Pharmaceuticals, Inc. | 8,053,298 | 19.0% | EDGAR |